APO Research

APO RESEARCH · REPORT

Collagen Peptides

Collagen widely exists in all multicellular animals. It is the most abundant protein in the body, accounting for about a quarter of the total protein in the human body. It is an extracellular protein in almost all tissues. It exists in the form of insoluble fibers and has high tensile capacity. It has great influence on the formation of skin, blood vessels, bones, tendons and cartilage in animals and human bodies It is an important material of connective tissue and a major factor determining the toughness of connective tissue. It plays a role of binding tissue in animal cells.

Product & engineering

Understand the product.

Collagen widely exists in all multicellular animals. It is the most abundant protein in the body, accounting for about a quarter of the total protein in the human body. It is an extracellular protein in almost all tissues. It exists in the form of insoluble fibers and has high tensile capacity. It has great influence on the formation of skin, blood vessels, bones, tendons and cartilage in animals and human bodies It is an important material of connective tissue and a major factor determining the toughness of connective tissue. It plays a role of binding tissue in animal cells.

Colloquially, collagen is only a part of collagen. Because the molecular weight of collagen ranges from 500 to 30000, the human body can directly absorb it. If it is too small, it is oligopeptide or polypeptide, which is no big difference from amino acid for human body. The larger molecular weight is hundreds of thousands to millions of macromolecules, which is collagen. Human body can't absorb collagen, which is the root of understanding that "collagen" can't be absorbed.

Selected research

Market Outlook & Growth Opportunities

Global Collagen Peptides Market Outlook and Growth Opportunities 2026

Market perspective

Collagen widely exists in all multicellular animals. It is the most abundant protein in the body, accounting for about a quarter of the total protein in the human body. It is an extracellular protein in almost all tissues. It exists in the form of insoluble fibers and has high tensile capacity. It has great influence on the formation of skin, blood vessels, bones, tendons and cartilage in animals and human bodies It is an important material of connective tissue and a major factor determining the toughness of connective tissue. It plays a role of binding tissue in animal cells.

Colloquially, collagen is only a part of collagen. Because the molecular weight of collagen ranges from 500 to 30000, the human body can directly absorb it. If it is too small, it is oligopeptide or polypeptide, which is no big difference from amino acid for human body. The larger molecular weight is hundreds of thousands to millions of macromolecules, which is collagen. Human body can't absorb collagen, which is the root of understanding that "collagen" can't be absorbed.

Global Collagen Peptides key players include Rousselot S.A.S., Gelita, PB Leiner, etc. Global top three manufacturers hold a share about 35%.

Read the full market overview

Europe is the largest market, with a share about 30%, followed by China, and North America, both have a share about 45 percent.

In terms of product, Porcine collagen is the largest segment, with a share about 35%. And in terms of application, the largest application is Food Industrial, followed by Health Products Industrial, Cosmetics Industrial, etc.

This report provides an overview of the global Collagen Peptides market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Collagen Peptides and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Collagen Peptides sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Collagen Peptides market size, projected growth trends, production technologies, key applications, and end-use industries.

Collagen Peptides Segment by Company

Rousselot S.A.S.

Gelita

PB Leiner

Nitta Gelatin Inc.

NIPPI

BHN

Weishardt International

Neocell

DCP

Lapi Gelatine

Italgelatine

Jiangxi Cosen Biology Co., Ltd

Tai AI peptide group

Beijing Huada Jierui Biotechnology Co., Ltd

Hainan Huayan Collagen Technology Co., Ltd.

Hynixon group

Mingrang biology

SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT.

Baotou Dongbao Bio-Tech Co.Ltd

Shanghai haijiantang group

Beijing SEMNL Biotechnology Co.ltd.

Guangdong Zhongnan Island Biotechnology Co., Ltd

Collagen Peptides Segment by Type

Fish collagen

Bovine collagen

Porcine collagen

Collagen Peptides Segment by Application

Food Industrial

Health Products Industrial

Cosmetics Industrial

Others

Collagen Peptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Collagen Peptides status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Collagen Peptides market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Collagen Peptides significant trends, drivers, influence factors in global and regions.

6. To analyze Collagen Peptides competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Collagen Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Collagen Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Collagen Peptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Collagen Peptides market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Collagen Peptides industry.

Chapter 3: Detailed analysis of Collagen Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Collagen Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Collagen Peptides in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Collagen Peptides Industry Trends Table 2. Collagen Peptides Industry Drivers Table 3. Collagen Peptides Industry Opportunities and Challenges Table 4. Collagen Peptides Industry Restraints Table 5. Global Collagen Peptides Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Collagen Peptides Revenue Share by Company (2021-2026) Table 7. Global Collagen Peptides Sales Volume by Company (t) & (2021-2026) Table 8. Global Collagen Peptides Sales Volume Share by Company (2021-2026) Table 9. Global Collagen Peptides Average Price (USD/t) of Company (2021-2026) Table 10. Global Collagen Peptides Company Ranking, (2024-2026) & (USD Million) Table 11. Global Collagen Peptides Key Company Manufacturing Base & Headquarters Table 12. Global Collagen Peptides Company, Product Type & Application Table 13. Global Collagen Peptides Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Collagen Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Fish collagen Table 18. Significant Companies of Bovine collagen Table 19. Significant Companies of Porcine collagen Table 20. Global Collagen Peptides Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 21. Global Collagen Peptides Sales Volume by Type (2021-2026) & (t) Table 22. Global Collagen Peptides Sales Volume by Type (2027-2032) & (t) Table 23. Global Collagen Peptides Sales Volume Share by Type (2021-2026) Table 24. Global Collagen Peptides Sales Volume Share by Type (2027-2032) Table 25. Global Collagen Peptides Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Collagen Peptides Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Collagen Peptides Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Collagen Peptides Sales Value Share by Type (2021-2026) Table 29. Global Collagen Peptides Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Food Industrial Table 31. Significant Companies of Health Products Industrial Table 32. Significant Companies of Cosmetics Industrial Table 33. Significant Companies of Others Table 34. Global Collagen Peptides Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 35. Global Collagen Peptides Sales Volume by Application (2021-2026) & (t) Table 36. Global Collagen Peptides Sales Volume by Application (2027-2032) & (t) Table 37. Global Collagen Peptides Sales Volume Share by Application (2021-2026) Table 38. Global Collagen Peptides Sales Volume Share by Application (2027-2032) Table 39. Global Collagen Peptides Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Collagen Peptides Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Collagen Peptides Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Collagen Peptides Sales Value Share by Application (2021-2026) Table 43. Global Collagen Peptides Sales Value Share by Application (2027-2032) Table 44. Global Collagen Peptides Sales by Region: 2021 VS 2025 VS 2032 (t) Table 45. Global Collagen Peptides Sales by Region (2021-2026) & (t) Table 46. Global Collagen Peptides Sales Market Share by Region (2021-2026) Table 47. Global Collagen Peptides Sales by Region (2027-2032) & (t) Table 48. Global Collagen Peptides Sales Market Share by Region (2027-2032) Table 49. Global Collagen Peptides Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Collagen Peptides Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Collagen Peptides Sales Value Share by Region (2021-2026) Table 52. Global Collagen Peptides Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Collagen Peptides Sales Value Share by Region (2027-2032) Table 54. Global Collagen Peptides Market Average Price (USD/t) by Region (2021-2026) Table 55. Global Collagen Peptides Market Average Price (USD/t) by Region (2027-2032) Table 56. Global Collagen Peptides Sales by Country: 2021 VS 2025 VS 2032 (t) Table 57. Global Collagen Peptides Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Collagen Peptides Sales by Country (2021-2026) & (t) Table 59. Global Collagen Peptides Sales Market Share by Country (2021-2026) Table 60. Global Collagen Peptides Sales by Country (2027-2032) & (t) Table 61. Global Collagen Peptides Sales Market Share by Country (2027-2032) Table 62. Global Collagen Peptides Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Collagen Peptides Sales Value Market Share by Country (2021-2026) Table 64. Global Collagen Peptides Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Collagen Peptides Sales Value Market Share by Country (2027-2032) Table 66. Rousselot S.A.S. Company Information Table 67. Rousselot S.A.S. Business Overview Table 68. Rousselot S.A.S. Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 69. Rousselot S.A.S. Collagen Peptides Product Portfolio Table 70. Rousselot S.A.S. Recent Development Table 71. Gelita Company Information Table 72. Gelita Business Overview Table 73. Gelita Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Gelita Collagen Peptides Product Portfolio Table 75. Gelita Recent Development Table 76. PB Leiner Company Information Table 77. PB Leiner Business Overview Table 78. PB Leiner Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. PB Leiner Collagen Peptides Product Portfolio Table 80. PB Leiner Recent Development Table 81. Nitta Gelatin Inc. Company Information Table 82. Nitta Gelatin Inc. Business Overview Table 83. Nitta Gelatin Inc. Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Nitta Gelatin Inc. Collagen Peptides Product Portfolio Table 85. Nitta Gelatin Inc. Recent Development Table 86. NIPPI Company Information Table 87. NIPPI Business Overview Table 88. NIPPI Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. NIPPI Collagen Peptides Product Portfolio Table 90. NIPPI Recent Development Table 91. BHN Company Information Table 92. BHN Business Overview Table 93. BHN Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. BHN Collagen Peptides Product Portfolio Table 95. BHN Recent Development Table 96. Weishardt International Company Information Table 97. Weishardt International Business Overview Table 98. Weishardt International Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Weishardt International Collagen Peptides Product Portfolio Table 100. Weishardt International Recent Development Table 101. Neocell Company Information Table 102. Neocell Business Overview Table 103. Neocell Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Neocell Collagen Peptides Product Portfolio Table 105. Neocell Recent Development Table 106. DCP Company Information Table 107. DCP Business Overview Table 108. DCP Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. DCP Collagen Peptides Product Portfolio Table 110. DCP Recent Development Table 111. Lapi Gelatine Company Information Table 112. Lapi Gelatine Business Overview Table 113. Lapi Gelatine Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. Lapi Gelatine Collagen Peptides Product Portfolio Table 115. Lapi Gelatine Recent Development Table 116. Italgelatine Company Information Table 117. Italgelatine Business Overview Table 118. Italgelatine Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Italgelatine Collagen Peptides Product Portfolio Table 120. Italgelatine Recent Development Table 121. Jiangxi Cosen Biology Co., Ltd Company Information Table 122. Jiangxi Cosen Biology Co., Ltd Business Overview Table 123. Jiangxi Cosen Biology Co., Ltd Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. Jiangxi Cosen Biology Co., Ltd Collagen Peptides Product Portfolio Table 125. Jiangxi Cosen Biology Co., Ltd Recent Development Table 126. Tai AI peptide group Company Information Table 127. Tai AI peptide group Business Overview Table 128. Tai AI peptide group Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 129. Tai AI peptide group Collagen Peptides Product Portfolio Table 130. Tai AI peptide group Recent Development Table 131. Beijing Huada Jierui Biotechnology Co., Ltd Company Information Table 132. Beijing Huada Jierui Biotechnology Co., Ltd Business Overview Table 133. Beijing Huada Jierui Biotechnology Co., Ltd Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 134. Beijing Huada Jierui Biotechnology Co., Ltd Collagen Peptides Product Portfolio Table 135. Beijing Huada Jierui Biotechnology Co., Ltd Recent Development Table 136. Hainan Huayan Collagen Technology Co., Ltd. Company Information Table 137. Hainan Huayan Collagen Technology Co., Ltd. Business Overview Table 138. Hainan Huayan Collagen Technology Co., Ltd. Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 139. Hainan Huayan Collagen Technology Co., Ltd. Collagen Peptides Product Portfolio Table 140. Hainan Huayan Collagen Technology Co., Ltd. Recent Development Table 141. Hynixon group Company Information Table 142. Hynixon group Business Overview Table 143. Hynixon group Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 144. Hynixon group Collagen Peptides Product Portfolio Table 145. Hynixon group Recent Development Table 146. Mingrang biology Company Information Table 147. Mingrang biology Business Overview Table 148. Mingrang biology Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 149. Mingrang biology Collagen Peptides Product Portfolio Table 150. Mingrang biology Recent Development Table 151. SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Company Information Table 152. SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Business Overview Table 153. SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 154. SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Collagen Peptides Product Portfolio Table 155. SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Recent Development Table 156. Baotou Dongbao Bio-Tech Co.Ltd Company Information Table 157. Baotou Dongbao Bio-Tech Co.Ltd Business Overview Table 158. Baotou Dongbao Bio-Tech Co.Ltd Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 159. Baotou Dongbao Bio-Tech Co.Ltd Collagen Peptides Product Portfolio Table 160. Baotou Dongbao Bio-Tech Co.Ltd Recent Development Table 161. Shanghai haijiantang group Company Information Table 162. Shanghai haijiantang group Business Overview Table 163. Shanghai haijiantang group Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 164. Shanghai haijiantang group Collagen Peptides Product Portfolio Table 165. Shanghai haijiantang group Recent Development Table 166. Beijing SEMNL Biotechnology Co.ltd. Company Information Table 167. Beijing SEMNL Biotechnology Co.ltd. Business Overview Table 168. Beijing SEMNL Biotechnology Co.ltd. Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 169. Beijing SEMNL Biotechnology Co.ltd. Collagen Peptides Product Portfolio Table 170. Beijing SEMNL Biotechnology Co.ltd. Recent Development Table 171. Guangdong Zhongnan Island Biotechnology Co., Ltd Company Information Table 172. Guangdong Zhongnan Island Biotechnology Co., Ltd Business Overview Table 173. Guangdong Zhongnan Island Biotechnology Co., Ltd Collagen Peptides Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 174. Guangdong Zhongnan Island Biotechnology Co., Ltd Collagen Peptides Product Portfolio Table 175. Guangdong Zhongnan Island Biotechnology Co., Ltd Recent Development Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Collagen Peptides Distributors List Table 179. Collagen Peptides Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Collagen Peptides Product Image Figure 2. Global Collagen Peptides Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Collagen Peptides Sales Value (2021-2032) & (US$ Million) Figure 4. Global Collagen Peptides Sales (2021-2032) & (t) Figure 5. Global Collagen Peptides Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Collagen Peptides Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Fish collagen Image Figure 10. Bovine collagen Image Figure 11. Porcine collagen Image Figure 12. Global Collagen Peptides Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Collagen Peptides Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Collagen Peptides Sales Volume Share by Type (2021-2032) Figure 15. Global Collagen Peptides Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Collagen Peptides Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Collagen Peptides Sales Value Share by Type (2021-2032) Figure 18. Food Industrial Image Figure 19. Health Products Industrial Image Figure 20. Cosmetics Industrial Image Figure 21. Others Image Figure 22. Global Collagen Peptides Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 23. Global Collagen Peptides Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Collagen Peptides Sales Volume Share by Application (2021-2032) Figure 25. Global Collagen Peptides Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Collagen Peptides Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Collagen Peptides Sales Value Share by Application (2021-2032) Figure 28. Global Collagen Peptides Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 29. Global Collagen Peptides Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Collagen Peptides Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Collagen Peptides Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Collagen Peptides Sales Value (2021-2032) & (US$ Million) Figure 33. North America Collagen Peptides Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Collagen Peptides Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Collagen Peptides Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Collagen Peptides Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Collagen Peptides Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Collagen Peptides Sales Value (2021-2032) & (US$ Million) Figure 39. South America Collagen Peptides Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Collagen Peptides Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Collagen Peptides Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Collagen Peptides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Collagen Peptides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Collagen Peptides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Collagen Peptides Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Collagen Peptides Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Fish collagen
  • Bovine collagen
  • Porcine collagen
Applications
  • Food Industrial
  • Health Products Industrial
  • Cosmetics Industrial
  • Others
Companies covered
  • Rousselot S.A.S.
  • Gelita
  • PB Leiner
  • Nitta Gelatin Inc.
  • NIPPI
  • BHN
  • Weishardt International
  • Neocell
  • DCP
  • Lapi Gelatine
  • Italgelatine
  • Jiangxi Cosen Biology Co., Ltd
  • Tai AI peptide group
  • Beijing Huada Jierui Biotechnology Co., Ltd
  • Hainan Huayan Collagen Technology Co., Ltd.
  • Hynixon group
  • Mingrang biology
  • SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT.
  • Baotou Dongbao Bio-Tech Co.Ltd
  • Shanghai haijiantang group
  • Beijing SEMNL Biotechnology Co.ltd.
  • Guangdong Zhongnan Island Biotechnology Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Collagen Peptides Sales Value (2021-2032)
  4. 1.2.2 Global Collagen Peptides Sales Volume (2021-2032)
  5. 1.2.3 Global Collagen Peptides Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Collagen Peptides Market Dynamics
  1. 2.1 Collagen Peptides Industry Trends
  2. 2.2 Collagen Peptides Industry Drivers
  3. 2.3 Collagen Peptides Industry Opportunities and Challenges
  4. 2.4 Collagen Peptides Industry Restraints
3 Collagen Peptides Market by Company
  1. 3.1 Global Collagen Peptides Company Revenue Ranking in 2025
  2. 3.2 Global Collagen Peptides Revenue by Company (2021-2026)
  3. 3.3 Global Collagen Peptides Sales Volume by Company (2021-2026)
  4. 3.4 Global Collagen Peptides Average Price by Company (2021-2026)
  5. 3.5 Global Collagen Peptides Company Ranking (2024-2026)
  6. 3.6 Global Collagen Peptides Company Manufacturing Base and Headquarters
  7. 3.7 Global Collagen Peptides Company Product Type and Application
  8. 3.8 Global Collagen Peptides Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Collagen Peptides Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Collagen Peptides Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Collagen Peptides Market by Type
  1. 4.1 Collagen Peptides Type Introduction
  2. 4.1.1 Fish collagen
  3. 4.1.2 Bovine collagen
  4. 4.1.3 Porcine collagen
  5. 4.2 Global Collagen Peptides Sales Volume by Type
  6. 4.2.1 Global Collagen Peptides Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Collagen Peptides Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Collagen Peptides Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Collagen Peptides Sales Value by Type
  10. 4.3.1 Global Collagen Peptides Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Collagen Peptides Sales Value by Type (2021-2032)
  12. 4.3.3 Global Collagen Peptides Sales Value Share by Type (2021-2032)
5 Collagen Peptides Market by Application
  1. 5.1 Collagen Peptides Application Introduction
  2. 5.1.1 Food Industrial
  3. 5.1.2 Health Products Industrial
  4. 5.1.3 Cosmetics Industrial
  5. 5.1.4 Others
  6. 5.2 Global Collagen Peptides Sales Volume by Application
  7. 5.2.1 Global Collagen Peptides Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Collagen Peptides Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Collagen Peptides Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Collagen Peptides Sales Value by Application
  11. 5.3.1 Global Collagen Peptides Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Collagen Peptides Sales Value by Application (2021-2032)
  13. 5.3.3 Global Collagen Peptides Sales Value Share by Application (2021-2032)
6 Collagen Peptides Regional Sales and Value Analysis
  1. 6.1 Global Collagen Peptides Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Collagen Peptides Sales by Region (2021-2032)
  3. 6.2.1 Global Collagen Peptides Sales by Region: 2021-2026
  4. 6.2.2 Global Collagen Peptides Sales by Region (2027-2032)
  5. 6.3 Global Collagen Peptides Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Collagen Peptides Sales Value by Region (2021-2032)
  7. 6.4.1 Global Collagen Peptides Sales Value by Region: 2021-2026
  8. 6.4.2 Global Collagen Peptides Sales Value by Region (2027-2032)
  9. 6.5 Global Collagen Peptides Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Collagen Peptides Sales Value (2021-2032)
  12. 6.6.2 North America Collagen Peptides Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Collagen Peptides Sales Value (2021-2032)
  15. 6.7.2 Europe Collagen Peptides Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Collagen Peptides Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Collagen Peptides Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Collagen Peptides Sales Value (2021-2032)
  21. 6.9.2 South America Collagen Peptides Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Collagen Peptides Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Collagen Peptides Sales Value Share by Country, 2025 VS 2032
7 Collagen Peptides Country-level Sales and Value Analysis
  1. 7.1 Global Collagen Peptides Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Collagen Peptides Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Collagen Peptides Sales by Country (2021-2032)
  4. 7.3.1 Global Collagen Peptides Sales by Country (2021-2026)
  5. 7.3.2 Global Collagen Peptides Sales by Country (2027-2032)
  6. 7.4 Global Collagen Peptides Sales Value by Country (2021-2032)
  7. 7.4.1 Global Collagen Peptides Sales Value by Country (2021-2026)
  8. 7.4.2 Global Collagen Peptides Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Collagen Peptides Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Collagen Peptides Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Collagen Peptides Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Collagen Peptides Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Collagen Peptides Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Collagen Peptides Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Collagen Peptides Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Collagen Peptides Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Collagen Peptides Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Collagen Peptides Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Collagen Peptides Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Collagen Peptides Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Collagen Peptides Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Collagen Peptides Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Collagen Peptides Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Collagen Peptides Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Collagen Peptides Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Collagen Peptides Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Collagen Peptides Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Collagen Peptides Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Collagen Peptides Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Collagen Peptides Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Collagen Peptides Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Collagen Peptides Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Collagen Peptides Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Collagen Peptides Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Collagen Peptides Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Collagen Peptides Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Collagen Peptides Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Collagen Peptides Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Collagen Peptides Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Rousselot S.A.S.
  2. 8.1.1 Rousselot S.A.S. Company Information
  3. 8.1.2 Rousselot S.A.S. Business Overview
  4. 8.1.3 Rousselot S.A.S. Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Rousselot S.A.S. Collagen Peptides Product Portfolio
  6. 8.1.5 Rousselot S.A.S. Recent Developments
  7. 8.2 Gelita
  8. 8.2.1 Gelita Company Information
  9. 8.2.2 Gelita Business Overview
  10. 8.2.3 Gelita Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Gelita Collagen Peptides Product Portfolio
  12. 8.2.5 Gelita Recent Developments
  13. 8.3 PB Leiner
  14. 8.3.1 PB Leiner Company Information
  15. 8.3.2 PB Leiner Business Overview
  16. 8.3.3 PB Leiner Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 PB Leiner Collagen Peptides Product Portfolio
  18. 8.3.5 PB Leiner Recent Developments
  19. 8.4 Nitta Gelatin Inc.
  20. 8.4.1 Nitta Gelatin Inc. Company Information
  21. 8.4.2 Nitta Gelatin Inc. Business Overview
  22. 8.4.3 Nitta Gelatin Inc. Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nitta Gelatin Inc. Collagen Peptides Product Portfolio
  24. 8.4.5 Nitta Gelatin Inc. Recent Developments
  25. 8.5 NIPPI
  26. 8.5.1 NIPPI Company Information
  27. 8.5.2 NIPPI Business Overview
  28. 8.5.3 NIPPI Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 NIPPI Collagen Peptides Product Portfolio
  30. 8.5.5 NIPPI Recent Developments
  31. 8.6 BHN
  32. 8.6.1 BHN Company Information
  33. 8.6.2 BHN Business Overview
  34. 8.6.3 BHN Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 BHN Collagen Peptides Product Portfolio
  36. 8.6.5 BHN Recent Developments
  37. 8.7 Weishardt International
  38. 8.7.1 Weishardt International Company Information
  39. 8.7.2 Weishardt International Business Overview
  40. 8.7.3 Weishardt International Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Weishardt International Collagen Peptides Product Portfolio
  42. 8.7.5 Weishardt International Recent Developments
  43. 8.8 Neocell
  44. 8.8.1 Neocell Company Information
  45. 8.8.2 Neocell Business Overview
  46. 8.8.3 Neocell Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Neocell Collagen Peptides Product Portfolio
  48. 8.8.5 Neocell Recent Developments
  49. 8.9 DCP
  50. 8.9.1 DCP Company Information
  51. 8.9.2 DCP Business Overview
  52. 8.9.3 DCP Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 DCP Collagen Peptides Product Portfolio
  54. 8.9.5 DCP Recent Developments
  55. 8.10 Lapi Gelatine
  56. 8.10.1 Lapi Gelatine Company Information
  57. 8.10.2 Lapi Gelatine Business Overview
  58. 8.10.3 Lapi Gelatine Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Lapi Gelatine Collagen Peptides Product Portfolio
  60. 8.10.5 Lapi Gelatine Recent Developments
  61. 8.11 Italgelatine
  62. 8.11.1 Italgelatine Company Information
  63. 8.11.2 Italgelatine Business Overview
  64. 8.11.3 Italgelatine Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Italgelatine Collagen Peptides Product Portfolio
  66. 8.11.5 Italgelatine Recent Developments
  67. 8.12 Jiangxi Cosen Biology Co., Ltd
  68. 8.12.1 Jiangxi Cosen Biology Co., Ltd Company Information
  69. 8.12.2 Jiangxi Cosen Biology Co., Ltd Business Overview
  70. 8.12.3 Jiangxi Cosen Biology Co., Ltd Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Jiangxi Cosen Biology Co., Ltd Collagen Peptides Product Portfolio
  72. 8.12.5 Jiangxi Cosen Biology Co., Ltd Recent Developments
  73. 8.13 Tai AI peptide group
  74. 8.13.1 Tai AI peptide group Company Information
  75. 8.13.2 Tai AI peptide group Business Overview
  76. 8.13.3 Tai AI peptide group Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Tai AI peptide group Collagen Peptides Product Portfolio
  78. 8.13.5 Tai AI peptide group Recent Developments
  79. 8.14 Beijing Huada Jierui Biotechnology Co., Ltd
  80. 8.14.1 Beijing Huada Jierui Biotechnology Co., Ltd Company Information
  81. 8.14.2 Beijing Huada Jierui Biotechnology Co., Ltd Business Overview
  82. 8.14.3 Beijing Huada Jierui Biotechnology Co., Ltd Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Beijing Huada Jierui Biotechnology Co., Ltd Collagen Peptides Product Portfolio
  84. 8.14.5 Beijing Huada Jierui Biotechnology Co., Ltd Recent Developments
  85. 8.15 Hainan Huayan Collagen Technology Co., Ltd.
  86. 8.15.1 Hainan Huayan Collagen Technology Co., Ltd. Company Information
  87. 8.15.2 Hainan Huayan Collagen Technology Co., Ltd. Business Overview
  88. 8.15.3 Hainan Huayan Collagen Technology Co., Ltd. Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Hainan Huayan Collagen Technology Co., Ltd. Collagen Peptides Product Portfolio
  90. 8.15.5 Hainan Huayan Collagen Technology Co., Ltd. Recent Developments
  91. 8.16 Hynixon group
  92. 8.16.1 Hynixon group Company Information
  93. 8.16.2 Hynixon group Business Overview
  94. 8.16.3 Hynixon group Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Hynixon group Collagen Peptides Product Portfolio
  96. 8.16.5 Hynixon group Recent Developments
  97. 8.17 Mingrang biology
  98. 8.17.1 Mingrang biology Company Information
  99. 8.17.2 Mingrang biology Business Overview
  100. 8.17.3 Mingrang biology Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Mingrang biology Collagen Peptides Product Portfolio
  102. 8.17.5 Mingrang biology Recent Developments
  103. 8.18 SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT.
  104. 8.18.1 SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Company Information
  105. 8.18.2 SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Business Overview
  106. 8.18.3 SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Collagen Peptides Product Portfolio
  108. 8.18.5 SHANGDONG ORIENTAL OCEAN SCI-TECH CO.,LDT. Recent Developments
  109. 8.19 Baotou Dongbao Bio-Tech Co.Ltd
  110. 8.19.1 Baotou Dongbao Bio-Tech Co.Ltd Company Information
  111. 8.19.2 Baotou Dongbao Bio-Tech Co.Ltd Business Overview
  112. 8.19.3 Baotou Dongbao Bio-Tech Co.Ltd Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Baotou Dongbao Bio-Tech Co.Ltd Collagen Peptides Product Portfolio
  114. 8.19.5 Baotou Dongbao Bio-Tech Co.Ltd Recent Developments
  115. 8.20 Shanghai haijiantang group
  116. 8.20.1 Shanghai haijiantang group Company Information
  117. 8.20.2 Shanghai haijiantang group Business Overview
  118. 8.20.3 Shanghai haijiantang group Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Shanghai haijiantang group Collagen Peptides Product Portfolio
  120. 8.20.5 Shanghai haijiantang group Recent Developments
  121. 8.21 Beijing SEMNL Biotechnology Co.ltd.
  122. 8.21.1 Beijing SEMNL Biotechnology Co.ltd. Company Information
  123. 8.21.2 Beijing SEMNL Biotechnology Co.ltd. Business Overview
  124. 8.21.3 Beijing SEMNL Biotechnology Co.ltd. Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Beijing SEMNL Biotechnology Co.ltd. Collagen Peptides Product Portfolio
  126. 8.21.5 Beijing SEMNL Biotechnology Co.ltd. Recent Developments
  127. 8.22 Guangdong Zhongnan Island Biotechnology Co., Ltd
  128. 8.22.1 Guangdong Zhongnan Island Biotechnology Co., Ltd Company Information
  129. 8.22.2 Guangdong Zhongnan Island Biotechnology Co., Ltd Business Overview
  130. 8.22.3 Guangdong Zhongnan Island Biotechnology Co., Ltd Collagen Peptides Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Guangdong Zhongnan Island Biotechnology Co., Ltd Collagen Peptides Product Portfolio
  132. 8.22.5 Guangdong Zhongnan Island Biotechnology Co., Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Collagen Peptides Value Chain Analysis
  2. 9.1.1 Collagen Peptides Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Collagen Peptides Sales Mode & Process
  6. 9.2 Collagen Peptides Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Collagen Peptides Distributors
  9. 9.2.3 Collagen Peptides Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research